Key Takeaways
- Lindsey Vonn's Olympic comeback bid concluded with a dramatic crash in the women's downhill at the 2026 Milano Cortina Winter Olympics, resulting in her airlift from the course for medical attention.
- The biotech sector is drawing attention from Goldman Sachs (GS) analysts for its robust growth potential in 2026, with certain "under-the-radar" companies like Halozyme Therapeutics (HALO) and Inovio Pharma (INO) identified by market observers as having the capacity for significant value appreciation, with some projecting over 200% upside.
- Prime Minister Sanae Takaichi's Liberal Democratic Party (LDP) is poised for a commanding victory in Japan's general election, with projections indicating the LDP and its coalition partner could secure approximately 300 of the 465 lower house seats.
- Vonn, 41, was reportedly competing with a ruptured ACL, making her attempt at an Olympic medal a challenging endeavor.
- The potential large majority for the LDP could empower Prime Minister Takaichi to advance her conservative agenda, despite market concerns over her proposed sales tax suspension.
Olympic Dreams Dashed: Lindsey Vonn's Crash at Milano Cortina 2026
American alpine skiing legend Lindsey Vonn's Olympic comeback ended abruptly on Sunday, February 8, 2026, with a severe crash during the downhill event at the Milano Cortina Winter Olympics. The 41-year-old athlete, reportedly competing with a ruptured ACL sustained just over a week ago, lost control merely 13 seconds into her run on the challenging Olimpia delle Tofane course in Cortina d'Ampezzo, Italy.
Vonn's right arm caught a gate on the first jump, sending her off balance and into a hard landing before she tumbled. Medical personnel attended to her on the slope for more than 10 minutes before she was airlifted by helicopter for further medical evaluation. This unfortunate incident marks the end of her highly anticipated return to Olympic competition, where she had hoped to secure another medal. The race was temporarily halted following her crash, with fellow American Breezy Johnson currently leading the women's downhill event. Vonn had previously crashed in a World Cup downhill race on January 30, 2026, a week before the Olympics, where she was seen limping and clutching her left knee.
Goldman Sachs Eyes Biotech for Explosive 2026 Growth
The biotech sector is generating considerable buzz among financial analysts, with Goldman Sachs (GS) experts predicting continued recovery and significant growth throughout 2026. Salveen Richter, lead U.S. biotech analyst at Goldman Sachs Research, highlighted the sector's potential for upside, particularly in large-cap companies like Amgen (AMGN) and Regeneron (REGN), while also noting a "laggard trade" opportunity in Biogen (BIIB). Richter also anticipates a broad increase in mergers and acquisitions (M&A) within the biotech group.
Beyond the established players, several "under-the-radar" biotech stocks are being touted for their potential to more than double in value. Halozyme Therapeutics (HALO) and Catalyst Pharmaceuticals (CPRX) are among those identified by market observers, showing double-digit increases in revenue and earnings per share (EPS). These companies are characterized by strong fundamentals, including profitability and low debt, making them attractive acquisition targets. Halozyme, for instance, is projecting impressive annual revenue growth of 28% to 35% and an EPS increase of at least 44% for 2026. Additionally, Inovio Pharma (INO) is another clinical-stage biotech company with a projected potential upside of 200% from current levels, with a high price estimate suggesting a 425% gain in the next 12 months. Terns Pharmaceuticals (TERN) is also on the radar, focusing on oncology after discontinuing some metabolic programs.
Japan's LDP Poised for Landslide Victory in General Election
Japan's political landscape is set for a significant shift as Prime Minister Sanae Takaichi's Liberal Democratic Party (LDP) and its coalition partner, the Japan Innovation Party, are on course for a large majority in the general election held on Sunday, February 8, 2026. Projections suggest the ruling coalition could secure approximately 300 seats in the 465-member House of Representatives, well exceeding the 233 seats required for a majority. Some polls even indicate a potential range of 274 to 328 seats for the LDP alone, and between 302 and 366 seats for the coalition.
This anticipated landslide victory would represent a substantial increase from the LDP's razor-thin majority following the 2024 election. Prime Minister Takaichi, Japan's first female leader, called the snap election to capitalize on her strong personal approval ratings. She has publicly vowed to resign if the coalition fails to secure a majority. The election comes amidst concerns over voter turnout, which was reported to be lower than the previous election as of 2 pm local time, partly due to heavy snowfall in some regions. Takaichi's campaign promise to suspend the 8% sales tax on food to alleviate household financial burdens had previously unsettled markets due to Japan's already substantial national debt.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.